Plain-English translation of NCT06571344 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is testing (a form of vitamin D) in people with advanced kidney disease who are on dialysis. Researchers will measure how well this medication works and whether it's safe by tracking vitamin D levels and related chemicals in the blood over time.
People on dialysis often have vitamin D deficiency, which can affect bone health and other important body functions. This trial aims to find out the best way to treat low vitamin D in dialysis patients and to understand how the medication affects their overall health.
You likely qualify if…
You likely don't qualify if…
You will take vitamin D supplements () as part of your regular dialysis care. Researchers will monitor your progress by regularly checking your blood levels—measuring vitamin D, calcium, phosphate, and other related markers—to see how well the treatment works and ensure it's safe for you. The study uses your existing medical records, so it fits into your normal dialysis routine.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Poland
Enrollment target
~160 participants
Started
November 2022
Primary completion
December 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in August 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Leszek Tylicki, Prof.
Medical University of Gdansk
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.